Table 3 Review of the literature[3, 4, 7, 8, 11, 16]-[49]
Phenotype | Total | Genotype | Sex1 | |||
|---|---|---|---|---|---|---|
GALNT3 | FGF23 | KL | Male | Female | ||
N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
Total | 56 (100) | 42 (75) | 13 (23) | 1 (2) | 30 (54) | 25 (46) |
Male | 29 (54) | 22 (52) | 8 (64) | 0 (0) | Â | Â |
Female | 25 (46) | 20 (48) | 5 (36) | 1 (100) | Â | Â |
HFTC | 30 (54) | 22 (52) | 8 (62) | 0 | 18 (60) | 12 (48) |
HHS | 6 (11) | 6 (14) | 0 | 0 | 3 (10) | 3 (12) |
HFTC + HHS | 20 (36) | 14 (33) | 5 (39) | 1 | 9 (30) | 10 (40) |
Dental involvement | 22 (39) | 18 (43) | 3 (23) | 1 | 13 (43) | 8 (32) |
Vascular calcification | 10 (18) | 6 (14) | 3 (23) | 1 | 3 (10) | 6 (24) |
Eye involvement | 9 (16) | 7 (17) | 2 (15) | 0 | 6 (20) | 3 (12) |